A 20-year study found favorable outcomes with IVIG in several difficult skin diseases, with side effects reported in 15.4% of patients.
Intravenous Immunoglobulin Shows Favorable Results in Skin Diseases
A 20-year study found favorable outcomes with IVIG in several difficult skin diseases, with side effects reported in 15.4% of patients.